Bevacizumab
ATC L01FG01 · 11 markets · 154 records
GB 26 records · 8 strengths
- 400 mg/16 mLinjectionAbevmy 400mg/16ml concentrate for solution for infusion vialsAlymsys 100mg/4ml concentrate for solution for infusion vials、Avastin 400mg/16ml solution for infusion vials、Aybintio 100mg/4ml solution for infusion vials、Bevqolva 100mg/4ml concentrate for solution for infusion vials、Oyavas 400mg/16ml concentrate for solution for infusion vials、Vegzelma 100mg/4ml concentrate for solution for infusion vials、Versavo 100mg/4ml concentrate for solution for infusion vials、Zirabev 100mg/4ml solution for infusion vials
- 100 mg/4 mLinjectionAbevmy 400mg/16ml concentrate for solution for infusion vialsAlymsys 100mg/4ml concentrate for solution for infusion vials、Avastin 400mg/16ml solution for infusion vials、Aybintio 100mg/4ml solution for infusion vials、Bevqolva 100mg/4ml concentrate for solution for infusion vials、Oyavas 400mg/16ml concentrate for solution for infusion vials、Vegzelma 100mg/4ml concentrate for solution for infusion vials、Versavo 100mg/4ml concentrate for solution for infusion vials、Zirabev 100mg/4ml solution for infusion vials
- 1.25 mginjectionAvastin 1.25mg/50microlitres solution for injection vialsManufacturer: Special Order
- 5 mg/0.2 mLinjectionManufacturer: Special Order ×7
- 3.75 mg/0.15 mLinjectionManufacturer: Special Order ×7
- 3 mg/0.12 mLinjectionManufacturer: Special Order ×7
- 2.5 mg/0.1 mLinjectionManufacturer: Special Order ×7
Records without a stated strength · 1 Manufacturer: Special Order
AU 23 records · 6 strengths
- 400 mg/16 mLinjectionABEVMYMVASI、Vegzelma
- 100 mg/4 mLinjectionABEVMYMVASI、Vegzelma
- 100 mginjectionABEVMY bevacizumab 400 mg/16 mL concentrate injection for solution vialMVASI bevacizumab 100 mg/4 mL injection concentrated vial、ONBEVZI bevacizumab 100 mg/4mL concentrated injection for intravenous infusion vial、VEGZELMA bevacizumab 100 mg/ 4 mL solution for intravenous infusion, vial、ZIRABEV bevacizumab 100 mg/ 4 mL concentrated solution for injection vial
- 400 mginjectionABEVMY bevacizumab 400 mg/16 mL concentrate injection for solution vialMVASI bevacizumab 100 mg/4 mL injection concentrated vial、ONBEVZI bevacizumab 100 mg/4mL concentrated injection for intravenous infusion vial、VEGZELMA bevacizumab 100 mg/ 4 mL solution for intravenous infusion, vial、ZIRABEV bevacizumab 100 mg/ 4 mL concentrated solution for injection vial
- 25 mg/mLinjectionBEVACIP bevacizumab 100 mg/4 mL concentrated solution for infusion vial
Records without a stated strength · 1 ABEVMY、BEVACIP、BEVACIPTIN、MVASI、Vegzelma
CA 15 records · 2 strengths
CN 15 records · 3 strengths
US 13 records · 4 strengths
ES 11 records · 4 strengths
MX 10 records · 1 strengths
Records without a stated strength · 1 BHAVA、BRITRO、CLESONIZ、EFFIVIA、JIMLY、LONGIVA、MONOPLAX、Vegzelma +2
HK 10 records · 1 strengths
Records without a stated strength · 1 ABEVMY CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/4ML、AVASTIN ROCHE CONCENTRATE FOR SOLN FOR INFUSION 100MG/4ML、AVASTIN ROCHE INJ 100MG/4ML、MVASI CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/4ML、Vegzelma concentrate for solution for infusion
EU 10 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 ABEVMY、ALYMSYS、Avastin、Avzivi、AYBINTIO、IPIQUE、MVASI、OYAVAS +2
SG 9 records · 7 strengths
- 400 mg/16 mLinjectionAVAMAB Concentrate for Solution for Infusion 100mg/4mL
- 100 mg/4 mLinjectionAVAMAB Concentrate for Solution for Infusion 100mg/4mL
- 400 mginjectionAvastin Concentrate for Solution for Infusion 100mg/4ml
- 25 mg/mLinjectionABEVMY™ CONCENTRATE FOR SOLUTION FOR INFUSION 25MG/MLMVASI CONCENTRATE FOR SOLUTION FOR INFUSION 25 MG/ML、VEGZELMA CONCENTRATE FOR SOLUTION FOR INFUSION 25 MG/ML
- 25 mginjectionAvastin Concentrate for Solution for Infusion 100mg/4ml
- 400 mg/vialinjectionZIRABEV CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/4 ML
- 100 mg/vialinjectionZIRABEV CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/4 ML
TW 5 records · 1 strengths
Records without a stated strength · 1 ABEVMY、Alymsys concentrate for solution for Infusion、Avastin、MVASI Solution for Injection、Vegzelma concentrate for solution for infusion、癌思停 注射劑、癌畢弭 注射劑、艾法施注射液 +2
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
6 more strength/form rows are recorded only in CA · SG · ES · TW and are not shown in this table. Hay 6 filas de concentración/forma registradas solo en CA · SG · ES · TW que no se muestran en esta tabla. 另有 6 个规格/剂型仅在 CA · SG · ES · TW 有记录(未在本表显示)。 另有 6 個規格/劑型僅在 CA · SG · ES · TW 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.